Navigation Links
Synthetic Genomics Inc. Purchases Patent Portfolio from Febit Holding GmbH
Date:9/17/2012

LA JOLLA, Calif., Sept. 17, 2012 /PRNewswire/ -- Synthetic Genomics Inc. (SGI), a privately held company developing and commercializing genomic-driven solutions to solve a range of global challenges, today announced they have purchased from Febit Holding GmbH the worldwide rights to three families of patents and patent applications related to key synthetic genomic technologies. All related know-how, equipment and technical support for implementation, were also purchased.

This newly acquired SGI technology includes methods for highly parallelized, low-cost oligonucleotide synthesis and retrieval of sequence-validated DNA.  Together, these technologies have the potential to drastically reduce the cost of DNA synthesis, a technical problem the synthetic biology community has faced since the first synthetic gene was produced forty years ago.

"The intellectual property from Febit will strengthen and accelerate SGI's ongoing development and commercialization of a variety of products including algae-based food and nutritional products, biofuels, biochemicals, synthetic vaccines and clean water," said J. Craig Venter, Ph.D., Founder and CEO, SGI. "The ability to construct accurate and inexpensive DNA, together with our current proprietary DNA assembly and genome transplantation methodologies, enable enhanced capacity to synthesize DNA and reprogram cells at a larger scale than what is currently achievable."

The newly acquired SGI patent families include seven issued United States and European patents covering methods to produce polymers, specifically double stranded, synthetic nucleic acids from a variety of oligonucleotides on a solid support; and methods for retrieving sequence verified synthetic nucleic acids following assembly on solid supports.  These methods can be used to quickly synthesize genetic components in parallel, and then selectively assemble the components having the perfect sequence into double stranded genes and larger DNA constructs with minimal errors.

About Synthetic Genomics Inc.

SGI, a privately held company founded in 2005, is dedicated to developing and commercializing genomic-driven solutions to address a wide range of global challenges. The company is focused on several key research and business programs including: developing algae biofuels in alliance with Exxon Mobil Research and Engineering Company, microbial-enhanced hydrocarbon recovery and conversion through an agreement with BP, new and improved food and nutritional products, and clean water technologies. SGI is also involved in synthetically derived vaccine development through Synthetic Genomic Vaccines Inc. (SGVI), a company co-founded with the J. Craig Venter Institute; and to developing sustainable crops and agricultural products through Agradis Inc., a company co-founded with Plenus S.A. de C.V. For more information go to: www.syntheticgenomics.com.

Media Contact: Heather Kowalski, 858-361-0466, hkowalski@syntheticgenomics.com


'/>"/>
SOURCE Synthetic Genomics Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. Synthetic Biology Market is Expected to Reach USD 16.7 Billion Globally in 2018: Transparency Market Research
2. Synthetic Biologics and Intrexon Corporation Enter Worldwide Exclusive Collaboration for Infectious Diseases
3. Discovered Evolution of Genomic Sequences -- from Ocean Archaea to Brain Cancer -- Leads to New Synthetic Replikin Vaccines for Infectious Diseases and Cancer
4. Synthetic Genomics Inc. Purchases 81 Acre Site in South California Desert for Scale up and Testing of Innovative Algae Strains
5. Synthetic Biologics Appoints Jeffrey J. Kraws as Independent Chairman
6. Synthetic Biologics Announces Completion of Enrollment in 164 Patient Clinical Trial of Oral Trimesta™ for Multiple Sclerosis
7. Synthetic Biologics to Present at ROTH Annual Growth Stock Conference
8. Adeona Becomes Synthetic Biologics, Inc.
9. Startling results in synthetic chemistry presented in Nature Chemistry
10. New England Biolabs Signs Agreement with Synthetic Genomics Inc. to Launch Gibson Assembly™ Master Mix for Molecular and Synthetic Biology Applications
11. Synthetic Genomics Inc. Hires Industry Leader George E. Stagnitti to Head Food and Nutritional Products Development Program
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/22/2017)... ... , ... Charm Sciences, Inc. is pleased to announce that its Charm Amphenicol ... as a screening test at dairies and farms for raw commingled cow milk. The ... EZ Lite system. These systems are a combination incubator and reader in one. , ...
(Date:6/20/2017)... ... June 20, 2017 , ... ... determine the adulterants which pose the most likely threat to their products at ... this year. , IFT's annual food expo attracts over 20,000 attendees representing ...
(Date:6/20/2017)... ... June 20, 2017 , ... Do More with OHAUS , With the ... trusted supplier in the weighing industry, to extending its expertise across the entire laboratory ... immunoassays, hybridizations and more, allowing for its customers to 'Do More' in ...
(Date:6/19/2017)... ... June 19, 2017 , ... EDETEK, Inc., a ... that it is launching two new additions of its award-winning cloud-based platform CONFORM™: ... at the DIA 2017 Annual Meeting in Chicago, IL, June 19-22, 2017. , ...
Breaking Biology Technology:
(Date:3/30/2017)... , March 30, 2017  On April 6-7, 2017, ... the Genome hackathon at Microsoft,s headquarters in ... competition will focus on developing health and wellness apps ... Hack the Genome is the first hackathon ... The world,s largest companies in the genomics, tech and ...
(Date:3/27/2017)... 27, 2017  Catholic Health Services (CHS) has ... Society (HIMSS) Analytics for achieving Stage 6 on ... . In addition, CHS previously earned a place ... an electronic medical record (EMR). "HIMSS ... of EMR usage in an outpatient setting.  This ...
(Date:3/22/2017)... March 21, 2017   Neurotechnology , a ... technologies, today announced the release of the ... provides improved facial recognition using up to 10 ... single computer. The new version uses deep neural-network-based ... and it utilizes a Graphing Processing Unit (GPU) ...
Breaking Biology News(10 mins):